This document outlines an initiative at Uppsala University to enhance drug discovery through automated phenotypic cell profiling using high-content imaging and AI. The research aims to integrate automation and intelligent experimental design to speed up the hypothesis generation, testing, and data analysis processes in biological labs. Key technologies mentioned include automated labs, advanced imaging techniques, and a focus on data-driven science to optimize drug development and safety assessments.